Pulmonary Clinical Trial - Bayer

Multispecialty

Status:

Startup

ClinicalTrials.gov:

NCT04813926

Bayer - Roar Registry

Drug

 Riociguat (Adempas, BAY63-2521)

Condition

Pulmonary Arterial Hypertension